You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis

  • Technology appraisal guidance
  • Reference number: TA254
  • Published:  25 April 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Multiple sclerosis (relapsing-remitting) - fingolimod: expert comments on the ACD

  • Multiple sclerosis (relapsing-remitting) - fingolimod: Matthews

  • Multiple sclerosis (relapsing-remitting) - fingolimod: Young


This page was last updated: 15 March 2012

Back to top